Intercardia, Astra Merck Inc. deal

Astra Merck and Intercardia, a majority owned subsidiary of Interneuron Pharmaceuticals Inc. (IPIC, Lexington, Mass.) signed a U.S. development and marketing agreement for bucindolol, a beta blocker agent that is being developed to treat moderate-to-severe congestive heart failure. The compound began Phase III trials in June. ...